Results

Total Results: 2,204 records

Showing results for "drugs".

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
    December 30, 2015 - We did not identify eligible trials of antihistaminergic drugs or alcohol. … We have added text describe how specific drugs or formulations can be used to target specific sleep … problems (Introduction: ‘Drugs can be specifically formulated…’). … One of the most commonly used drugs for insomnia. No evidence. … Drugs Aging. 2014 Oct;31(10):731-6. doi: 10.1007/s40266-014-0211-3.
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-finding-evidence_methods.pdf
    January 01, 2011 - These approval documents—which can be found at Drugs@FDA.gov—may help identify publication bias even … Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. 46. … Ottawa: Canadian Agency for Drugs and Technologies in Health. … an pharmaceuticals, more non-U.S. coverage than MEDLINE Avenell, 2001 Minozzi, 2000 Sampson, … and pharmaceuticals Fishman, 1996 Wolfe, 2002 MANTIS (Manual Alternative and Natural Therapy Index
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ced-topic-refinement.pdf
    November 01, 2022 - Medicare beneficiaries.1 Thus, CMS makes decisions about providing insurance coverage for use of these drugs … For studies that involve researching the safety and effectiveness of new drugs and biological products … For studies that involve researching the safety and effectiveness of new drugs and biological products … there may not be the extensive clinical trial record that is generated during regulatory approval of pharmaceuticals … Specification for Cancer Drugs Fund data collection arrangements.
  4. Obesity (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the four topics for which (1) preliminary phase III data for drugs or … interventions in this Executive Summary and report is organized alphabetically by device and then, pharmaceuticals … phentermine- topiramate (Qsymia®, Vivus, Inc., Mountain View, CA) and lorcaserin (Belviq®, Arena Pharmaceuticals
  5. Insomnia Executive (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/insomnia_executive.pdf
    December 01, 2015 - Prescription drugs are often used to treat insomnia. … We found the most data on the newer FDA-approved drugs. … Results for adverse effects varied across the different drugs and typically were not different from … Drug trials for certain drugs often used doses that are no longer recommended by the FDA. … Drug Class Review: Newer Drugs for Insomnia: Final Report Update 2 [Internet].
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0075_03-10-2009.pdf
    January 01, 2009 - corticosteroids, immune system suppressors, antibiotics, anti-diarrheals, anti-tumor necrosis factor (TNF) drugs
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0313_02-09-2009.pdf
    January 01, 2009 - A number of drugs and dietary measures have been shown to reduce the rate of stone recurrence.
  8. effectivehealthcare-admin.ahrq.gov/health-topics/carbohydrates?page=2
    January 01, 2005 - Knowledge Gaps in Type 2 Diabetes Therapeutics: Comparative Effectiveness and Safety of Oral Antidiabetic Drugs
  9. Diabetes Mellitus (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … drug in some state Medicare drug plan formularies, which is the highest pricing tier for specialty pharmaceuticals … San Diego (CA): Amylin Pharmaceuticals, Inc.; 2012 Jan 27 [accessed 2014 Apr 10]. [5 p].
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
    April 01, 2011 - Drugs that are not approved by the FDA have been removed. … Drugs that are not approved by the FDA have been removed. … Weiglein; Takeda Pharmaceuticals North America, Inc Results 1. … Weiglein; Takeda Pharmaceuticals North America, Inc Results 1. … Weiglein; Takeda Pharmaceuticals North America, Inc Discussion 1.
  11. effectivehealthcare-admin.ahrq.gov/products/allergy-seasonal/research-protocol
    December 01, 2020 - Six classes of drugs and nasal saline are used to treat SAR. … Several drugs have more than one route of administration (e.g., intranasal and oral), as described below … These drugs are commonly administered prophylactically, before an allergic reaction is triggered, during … for clinical trials, data demonstrating efficacy and maternal and fetal safety are lacking for most drugs … Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory Information/Guidances/
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dementia-databases-methods_research.pdf
    May 01, 2008 - Use of anti-dementia drugs was similar across settings, with 24.7% of dementia cases in the community … larger than in the community, but there is little difference in the proportions receiving anti-dementia drugs … In a previous study, the authors13 reviewed 81 recent randomized clinical trials of dementia drugs … Our analysis of drugs typically used to treat behavioral manifestations of dementia found that treatment … these utilization rates are not adjusted for potential confounding factors, we cannot conclude the drugs
  13. S149 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/s149.pdf
    October 01, 2007 - longitudinal pro- pensity score to compare outcomes between a new drug (exenatide) and established drugs … We used our methods to estimate the effect of the new versus established drugs on total health care charges … Additionally, a separate, linkable file is available which includes pharmacy claims for prescription drugs … May 2005 14,052 0.00 0.46 0.45 Emergency room visit June 2005 36 0.00 0.47 0.49 No. drugs June 2005 … This methodology has particular value for the study of new drugs.
  14. effectivehealthcare-admin.ahrq.gov/products/methods-guidance-harms/methods
    May 01, 2020 - for most regulatory approvals, and the source of most advertising and other claims made on behalf of drugs … For example, a systematic review of nonsteroidal anti-inflammatory drugs (NSAIDs) found cyclo-oxygenase … Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and … A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs … Causality assessment of adverse reactions to drugs-I.
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
    December 29, 2020 - Dosing of nonsteroidal anti-inflammatory drugs (NSAIDS). … No not everyone who is on an opiod ends up on street drugs. … This war on drugs came into existence during the Nixon era. … We still have more people overdosing on drugs and alcohol than ever before. … It is illegal drugs that are causing our problem and lack of education of our citizens.
  16. effectivehealthcare-admin.ahrq.gov/health-topics/liver-diseases
    October 23, 2014 - Diseases caused by viruses, such as hepatitis A, hepatitis B , and hepatitis C Diseases caused by drugs
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0108_05-24-2009.pdf
    January 01, 2009 - migraine patients require multiple doses and often do not relieve the migraine and that some other drugs
  18. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … below lists the three topics for which (1) preliminary phase III or bioequivalence study data for drugs
  19. Diabetes Mellitus (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
    September 26, 2014 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Results The table below lists the six topics for which (1) preliminary phase III data for drugs, at … of this therapy for both drugs. … Intarcia Therapeutics, Inc., Hayward, CA), is extended-release exenatide for injection (Bydureon™, Amylin Pharmaceuticals … Get drugs straight to the eye. [internet].
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
    February 01, 2024 - Drugs Aging. 2013 Oct;30(10):793- 807. doi: 10.1007/s40266-013-0106-8. PMID: 23912674. 11. … Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials. … Drugs Aging. 2019 Dec;36(12):1097-110. doi: 10.1007/s40266-019-00717-1. PMID: 31598908. … Withdrawal of antihypertensive drugs in older people. … Drugs Aging. 2013 Oct;30(10):793-807. doi: 10.1007/s40266-013-0106-8. PMID: 23912674.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: